ES2075160T3 - Dispositivo para la administracion transdermica bifasica de drogas. - Google Patents

Dispositivo para la administracion transdermica bifasica de drogas.

Info

Publication number
ES2075160T3
ES2075160T3 ES90308915T ES90308915T ES2075160T3 ES 2075160 T3 ES2075160 T3 ES 2075160T3 ES 90308915 T ES90308915 T ES 90308915T ES 90308915 T ES90308915 T ES 90308915T ES 2075160 T3 ES2075160 T3 ES 2075160T3
Authority
ES
Spain
Prior art keywords
drug
biphasic
drugs
during
discharge
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90308915T
Other languages
English (en)
Inventor
Miranda Jesus
Gary W Cleary
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cygnus Therapeutic Systems
Original Assignee
Cygnus Therapeutic Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cygnus Therapeutic Systems filed Critical Cygnus Therapeutic Systems
Application granted granted Critical
Publication of ES2075160T3 publication Critical patent/ES2075160T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Surgical Instruments (AREA)

Abstract

SE PROPORCIONA UN SISTEMA DE DESCARGA DE DROGA TRANSDERMAL EN EL QUE LA DESCARGA DE LA DROGA ES EN DOS FASES. LA DROGA SE DESCARGA EN UNA TASA EFECTIVA TERAPEUTICAMENTE DURANTE UNA FASE DE DESCARGA INICIAL, NORMALMENTE DE ENTRE 10 Y 14 HORAS, SEGUIDA DE UNA FASE SECUNDARIA SUBSIGUIENTE DURANTE LA QUE VIRTUALMENTE NO SE DESCARGA NINGUNA DROGA. ESENCIALMENTE TODA LA DROGA INICIALMENTE CARGADA EN EL DISPOSITIVO SE DESCARGA DURANTE LA FASE DE DESCARGA INICIAL.
ES90308915T 1989-08-15 1990-08-14 Dispositivo para la administracion transdermica bifasica de drogas. Expired - Lifetime ES2075160T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/394,096 US5091186A (en) 1989-08-15 1989-08-15 Biphasic transdermal drug delivery device

Publications (1)

Publication Number Publication Date
ES2075160T3 true ES2075160T3 (es) 1995-10-01

Family

ID=23557536

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90308915T Expired - Lifetime ES2075160T3 (es) 1989-08-15 1990-08-14 Dispositivo para la administracion transdermica bifasica de drogas.

Country Status (13)

Country Link
US (1) US5091186A (es)
EP (1) EP0413553B1 (es)
JP (1) JPH04507256A (es)
AT (1) ATE124276T1 (es)
AU (1) AU648990B2 (es)
CA (1) CA2064765C (es)
DE (1) DE69020458T2 (es)
ES (1) ES2075160T3 (es)
FI (1) FI920601A0 (es)
IE (1) IE67774B1 (es)
NZ (1) NZ234881A (es)
PT (1) PT95014A (es)
WO (1) WO1991002506A1 (es)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5358715A (en) * 1992-09-02 1994-10-25 Cygnus Therapeutic Systems Enhancement of transdermal drug delivery using monoalkyl phosphates and other absorption promoters
US5308625A (en) * 1992-09-02 1994-05-03 Cygnus Therapeutic Systems Enhancement of transdermal drug delivery using monoalkyl phosphates and other absorption promoters
US5613958A (en) * 1993-05-12 1997-03-25 Pp Holdings Inc. Transdermal delivery systems for the modulated administration of drugs
WO1995001766A1 (en) * 1993-07-09 1995-01-19 Cygnus Therapeutic Systems Method and device for providing nicotine replacement therapy transdermally/transbuccally
DE4445003A1 (de) * 1994-12-16 1996-06-20 Fhw Feucht Hygiene Werk Gmbh Desinfizierendes Mittel
CA2223588C (en) 1995-06-07 2004-01-06 Noven Pharmaceuticals, Inc. Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures
FR2735024B1 (fr) * 1995-06-08 1997-11-28 Sanofi Sa Dispositif d'administration cutanee d'un produit medicamenteux ou cosmetique.
US5807570A (en) * 1995-09-29 1998-09-15 Cygnus, Inc. Transdermal administration of ropinirole and analogs thereof
US5968547A (en) 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
JP4477152B2 (ja) * 1997-05-16 2010-06-09 株式会社共和 ストーマ用又は瘡傷用の皮膚保護材
IT1294748B1 (it) 1997-09-17 1999-04-12 Permatec Tech Ag Formulazione per un dispositivo transdermico
ATE241363T1 (de) * 1998-02-11 2003-06-15 Rtp Pharma Corp Ungesättigte fettsäure und steroide enthaltende kombinationspräparate zur behandlung von entzündungen
DE19814084B4 (de) * 1998-03-30 2005-12-22 Lts Lohmann Therapie-Systeme Ag D2-Agonist enthaltendes transdermales therapeutisches System zur Behandlung des Parkinson-Syndroms und Verfahren zu seiner Herstellung
US6337328B1 (en) 1999-03-01 2002-01-08 Sepracor, Inc. Bupropion metabolites and methods of use
DE10041478A1 (de) * 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung
US7018649B2 (en) * 2000-10-23 2006-03-28 Euro-Celtique, S.A. Felodipine transdermal device and methods
ATE460928T1 (de) * 2000-10-23 2010-04-15 Euro Celtique Sa Transdermales system zur verabreichung von loratadin und dessen verwendung
US6682757B1 (en) 2000-11-16 2004-01-27 Euro-Celtique, S.A. Titratable dosage transdermal delivery system
US20030026830A1 (en) * 2001-05-08 2003-02-06 Thomas Lauterback Transdermal therapeutic system for parkinson's disease inducing high plasma levels of rotigotine
US20030027793A1 (en) * 2001-05-08 2003-02-06 Thomas Lauterback Transdermal treatment of parkinson's disease
GB0210397D0 (en) * 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
AU2003240301B2 (en) 2002-06-25 2008-02-14 Acrux Dds Pty Ltd Transdermal delivery rate control using amorphous pharmaceutical compositions
DE10234673B4 (de) * 2002-07-30 2007-08-16 Schwarz Pharma Ag Heißschmelz-TTS zur Verabreichung von Rotigotin und Verfahren zu seiner Herstellung sowie Verwendung von Rotigotin bei der Herstellung eines TTS im Heißschmelzverfahren
US8246980B2 (en) * 2002-07-30 2012-08-21 Ucb Pharma Gmbh Transdermal delivery system
US8246979B2 (en) 2002-07-30 2012-08-21 Ucb Pharma Gmbh Transdermal delivery system for the administration of rotigotine
US8211462B2 (en) * 2002-07-30 2012-07-03 Ucb Pharma Gmbh Hot-melt TTS for administering rotigotine
US20040029959A1 (en) * 2002-08-08 2004-02-12 John Devane Isosorbide mononitrate compositions and methods of their use
SI1426049T1 (en) * 2002-12-02 2005-08-31 Sanol Arznei Schwarz Gmbh Iontophoretic delivery of rotigotine for the treatment of Parkinson's disease
DE10261696A1 (de) * 2002-12-30 2004-07-15 Schwarz Pharma Ag Vorrichtung zur transdermalen Verabreichung von Rotigotin-Base
AU2005244096B2 (en) 2004-05-07 2011-03-17 Algenis Spa Transdermal administration of phycotoxins
WO2006135785A2 (en) * 2005-06-10 2006-12-21 Medical College Of Georgia Research Institute Compositions and methods for treating immune disorders
US9446017B2 (en) 2005-08-11 2016-09-20 Augusta University Research Institute, Inc. Compositions and methods for treating herpes simplex virus
US7740879B2 (en) * 2006-01-17 2010-06-22 Harrogate Holdings Abuse resistant transdermal drug delivery patch
US9114133B2 (en) 2006-08-25 2015-08-25 U.S. Dept. Of Veterans Affairs Method of improving diastolic dysfunction
CA2695634C (en) 2007-08-06 2018-01-23 Serenity Pharmaceuticals Corporation Methods and devices for desmopressin drug delivery
HUE030409T2 (en) * 2008-05-21 2017-05-29 Ferring Bv Orodispersible desmopressin preparation to increase the length of the initial period of sleep disturbed by nocturia
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
WO2011014775A1 (en) 2009-07-31 2011-02-03 The Brigham And Women's Hospital, Inc. Modulation of sgk1 expression in th17 cells to modulate th17-mediated immune responses
WO2011127232A2 (en) 2010-04-08 2011-10-13 Emory University Substituted androst-4-ene diones
CA2830069C (en) 2011-03-20 2019-11-12 The University Of British Columbia Therapeutic agent for emphysema and copd
US9480696B2 (en) 2011-05-04 2016-11-01 Trustees Of Boston University Proton-motive force stimulation to potentiate aminoglycoside antibiotics against persistent bacteria
US20140227293A1 (en) 2011-06-30 2014-08-14 Trustees Of Boston University Method for controlling tumor growth, angiogenesis and metastasis using immunoglobulin containing and proline rich receptor-1 (igpr-1)
EP2543370A1 (en) 2011-07-06 2013-01-09 Georgia Health Sciences University Research Institute, Inc. Compositions and Methods for Treating Herpes Simplex Virus
US9243037B2 (en) 2011-11-10 2016-01-26 Trustees Of Boston College Gramicidin a mutants that function as antibiotics with improved solubility and reduced toxicity
EP2938391B1 (en) 2012-12-28 2022-07-27 Teikoku Seiyaku Co., Ltd. Extended buprenorphine transdermal delivery compositions
WO2014130922A1 (en) 2013-02-25 2014-08-28 Trustees Of Boston University Compositions and methods for treating fungal infections
EP3036226B1 (en) 2013-08-22 2020-01-08 The General Hospital Corporation Inhibitors of human 12/15-lipoxygenase
US11382883B2 (en) 2013-08-29 2022-07-12 Trustees Of Boston University Intermediate metabolism products to potentiate aminoglycoside antibiotics in bacterial infections
WO2016196664A1 (en) 2015-06-01 2016-12-08 Cedars-Sinai Medical Center Methods and use of compounds that bind to rela of nf-kb
WO2017017631A2 (en) 2015-07-28 2017-02-02 Vyome Biosciences Pvt. Ltd. Antibacterial therapeutics and prophylactics

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3854480A (en) * 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
US3797494A (en) * 1969-04-01 1974-03-19 Alza Corp Bandage for the administration of drug by controlled metering through microporous materials
US3964482A (en) * 1971-05-17 1976-06-22 Alza Corporation Drug delivery device
US3742951A (en) * 1971-08-09 1973-07-03 Alza Corp Bandage for controlled release of vasodilators
US3996934A (en) * 1971-08-09 1976-12-14 Alza Corporation Medical bandage
US3921636A (en) * 1973-01-15 1975-11-25 Alza Corp Novel drug delivery device
US4036227A (en) * 1973-04-25 1977-07-19 Alza Corporation Osmotic releasing device having a plurality of release rate patterns
US3923939A (en) * 1974-06-07 1975-12-02 Alza Corp Process for improving release kinetics of a monolithic drug delivery device
CA1163561A (en) * 1979-11-06 1984-03-13 Cyril Boroda Preparation containing nitroglycerine and optionally other medicaments and preparation thereof
US4286592A (en) * 1980-02-04 1981-09-01 Alza Corporation Therapeutic system for administering drugs to the skin
US4336243A (en) * 1980-08-11 1982-06-22 G. D. Searle & Co. Transdermal nitroglycerin pad
IL61721A (en) * 1980-12-16 1984-03-30 Blank Izhak Nitroglycerin preparations
US4661105A (en) * 1981-06-29 1987-04-28 Alza Corporation Medical bandage for administering vasodilator drug
US4725272A (en) * 1981-06-29 1988-02-16 Alza Corporation Novel bandage for administering beneficial drug
US4650484A (en) * 1983-02-03 1987-03-17 Alza Corporation Method for treating ischemic conditions
US4704119A (en) * 1983-02-03 1987-11-03 Alza Corporation Method comprising transdermal and buccal treatment of angina
DE3305935C2 (de) * 1983-02-21 1985-05-30 Medice Chem.-Pharm. Fabrik Pütter GmbH & Co KG, 5860 Iserlohn Kaliumneutrales Saluretikum mit antihypertensiver Wirkung
US4559222A (en) * 1983-05-04 1985-12-17 Alza Corporation Matrix composition for transdermal therapeutic system
US4605548A (en) * 1983-05-31 1986-08-12 Nitto Electric Industrial Co., Ltd. Drug administration material
US4601893A (en) * 1984-02-08 1986-07-22 Pfizer Inc. Laminate device for controlled and prolonged release of substances to an ambient environment and method of use
US4786282A (en) * 1985-02-26 1988-11-22 Adria Laboratories Bandage for the topical administration of controlled amounts of nitroglycerin ointment
US4751087A (en) * 1985-04-19 1988-06-14 Riker Laboratories, Inc. Transdermal nitroglycerin delivery system
US4681584A (en) * 1985-05-03 1987-07-21 Alza Corporation Transdermal delivery system for delivering nitroglycerin at high transdermal fluxes
US4615699A (en) * 1985-05-03 1986-10-07 Alza Corporation Transdermal delivery system for delivering nitroglycerin at high transdermal fluxes
DE3518707A1 (de) * 1985-05-24 1986-11-27 Beiersdorf Ag, 2000 Hamburg Nitro-pflaster
US4655766A (en) * 1985-08-01 1987-04-07 Alza Corporation Fluid imbibing pump with self-regulating skin patch
US4717568A (en) * 1985-08-09 1988-01-05 Alza Corporation Laminar arrangement for increasing delivery of beneficial agent from dispenser
US4698062A (en) * 1985-10-30 1987-10-06 Alza Corporation Medical device for pulsatile transdermal delivery of biologically active agents
US4666441A (en) * 1985-12-17 1987-05-19 Ciba-Geigy Corporation Multicompartmentalized transdermal patches
US4723957A (en) * 1986-02-07 1988-02-09 Alza Corp. System for delivering drug with enhanced bioacceptability
US4830690A (en) * 1986-05-05 1989-05-16 Diane Cooper Method for making an art work from colored adhesives
DE3617158C2 (de) * 1986-05-22 1994-10-06 Lohmann Therapie Syst Lts Transdermales Arzneimittel
US4784857A (en) * 1986-06-03 1988-11-15 Smith And Nephew Associated Companies Plc Drug delivery device, its preparation and use
ES2028074T3 (es) * 1986-06-13 1992-07-01 Alza Corporation Activacion por humedad de un sistema de suministro transdermico de farmacos.
US4906463A (en) * 1986-12-22 1990-03-06 Cygnus Research Corporation Transdermal drug-delivery composition
US4746515A (en) * 1987-02-26 1988-05-24 Alza Corporation Skin permeation enhancer compositions using glycerol monolaurate
US4906643A (en) * 1987-07-17 1990-03-06 Janssen Pharmaceutica N.V. Substituted N-(3-hydroxy-4-piperidinyl)benzamides as gastrointestinal agents
US4898920A (en) * 1987-10-15 1990-02-06 Dow Corning Corporation Adhesive compositions, controlled release compositions and transdermal delivery device
JP2639416B2 (ja) * 1988-04-23 1997-08-13 財団法人化学及血清療法研究所 真珠生産用二枚貝の血球活性化製剤および該製剤を用いる真珠の生産方法

Also Published As

Publication number Publication date
AU648990B2 (en) 1994-05-12
DE69020458T2 (de) 1995-11-09
JPH04507256A (ja) 1992-12-17
EP0413553A1 (en) 1991-02-20
IE67774B1 (en) 1996-04-17
EP0413553B1 (en) 1995-06-28
US5091186A (en) 1992-02-25
WO1991002506A1 (en) 1991-03-07
PT95014A (pt) 1991-04-18
DE69020458D1 (de) 1995-08-03
CA2064765A1 (en) 1991-02-16
NZ234881A (en) 1992-02-25
ATE124276T1 (de) 1995-07-15
AU6296290A (en) 1991-04-03
FI920601A0 (fi) 1992-02-12
IE902947A1 (en) 1991-04-10
CA2064765C (en) 1995-09-12

Similar Documents

Publication Publication Date Title
ES2075160T3 (es) Dispositivo para la administracion transdermica bifasica de drogas.
ATE234602T1 (de) Verabreichungsform zur abgabe von steigenden wirkstoffdosen
CA2240329A1 (en) Improved delivery of multiple doses of medications
FI945621A (fi) Säädetysti vapauttava valmiste
ES2170069T3 (es) 1-alfa-hidroxiprevitamina d para administracion oral.
PT932388E (pt) Forma de dosagem e metodo para administracao de farmacos
WO1994027589A3 (en) Antidepressant dosage form
DK0642788T3 (da) Tramadolsaltholdigt lægemiddel med forsinket frigivelse af aktivt stof
NZ508526A (en) Opioid formulations for treating pain
BRPI0410542A (pt) dispositivo de administração de medicamento para um olho e método de administrar um agente farmaceuticamente ativo a um olho
IE821214L (en) Medicament
BR9802537A (pt) Método para anestesiar um paciente humano antes de cirurgias de porte dose unitária e sistema farmacêutico para administração
ES2171459T3 (es) Polvo para administracion nasal de farmaco peptidico o proteinaceo.
NO892764D0 (no) Medikamentell administreringsform for droevtyggere.
ATE295157T1 (de) Mittel zur transdermalen verabreichung von arzneistoffen
TR199801184T2 (xx) Analjezik tesirli yeni bile�ikler.
BR9910201A (pt) Sistema terapêutico transdérmico para emprego de candesartan
FR2778108B1 (fr) Dispositif d'administration transdermique de medicament par ionophorese
DK408188A (da) Injicerbart middel til kontrolleret frigivelse af opioid-analgetika
FR2749586B1 (fr) Nouveaux dispositifs destines a l'administration transdermique de la trimegestone, leur procede de preparation et leur application a titre de medicaments
BR9607488A (pt) Um sistema terapêutico transdérmico para a administração de (s)-3-metil-5-(1-metil-2-pirrolidenil)-isoxazol ou um dos seus sais farmaceuticamente aceítaveis
ES2053834T3 (es) Un metodo para la preparacion de una sustancia terapeutica.
DE69724228D1 (de) Kombinationstherapie von topoisomerase ii toxinen und bis-dioxypiperazinderivaten
DE59908258D1 (de) Blister enthaltend ein transdermales therapeutisches system und eine einzeldosierte darreichungsform
ITMI921573A0 (it) Dispositivo di somministrazione di farmaci particolarmente per aerosolterapia e simili

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 413553

Country of ref document: ES